World Health Organization class III COPD-associated pulmonary hypertension: Are we there yet in understanding the pathobiology of the disease?

Chest

Volumn 136, Issue 3, 2009, Pages 658-659

  Steiner, M Kathryn ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; EDITORIAL; EMPHYSEMA; FRANCE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART CATHETERIZATION; HEART DISEASE; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; WORLD HEALTH ORGANIZATION;

EID: 70049102586     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0896     Document Type: Editorial

References (15)

1. Simmoneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S
2. Ooi H, Cadogan E, Sweeney M, et al. Chronic hypercapnia inhibits hypoxic pulmonary vascular remodeling. Am J Physiol Heart Circ Physiol 2000; 278:H331-H338 (Pubitemid 30131230)
3. Weissmann N, Manz D, Buchspies D, et al. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost 2005; 94:630-638
4. Von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946; 12:301-320
5. Weiztenblum E. Chronic cor pulmonale. Heart 2003; 89:225-230
6. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166:314-322 (Pubitemid 34864419)
7. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:189-194 (Pubitemid 40981192)
8. Kessler R, Faller M, Weitzenblum E, et al. "Natural History" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:219-224
9. Weitzenblum E, Chaouat A. Severe pulmonary hypertension in COPD: is it a distinct disease? Chest 2005; 127:1480-1482
10. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest 1995; 107:1193-1198
11. Wright JL, Petty T, Thurlbeck WM. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 1992; 170: 109-124
12. Walter RE, Wilk JB, Larson MG. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008; 133:19-25
13. Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009; 104:236-244
14. Chaouat A, Savale L, Chouaid C, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136: 678-687
15. Machado RD, Koehler R, Glissmeyer E, et al. Genetic association of the serotonin transporter in pulmonary artery hypertension. Am J Respir Crit Care Med 2006; 173:793-797